Clinical Study of Patients Treated With PuraBond Haemostatic Agent During Abdominal Aorta Open Repair
NCT: NCT05733585 · RECRUITING
Brief Summary
Purabond Study is a physician-initiated, observational, monocentric prospective Trial. The aim of the study is to investigate the hemostatic efficacy of PuraBond for aortic anastomoses and suture lines in patients with abdominal aortic pathology (aneurysmal or steno occlusive disease) candidate to open repair at Vascular Surgery Departement - San Raffaele Hospital (Milan, Italy). The Study will include 100 patients.
Frequently Asked Questions
What is Clinical Study of Patients Treated With PuraBond Haemostatic Agent During Abdominal Aorta Open Repair?
Clinical Study of Patients Treated With PuraBond Haemostatic Agent During Abdominal Aorta Open Repair is a clinical trial registered under NCT05733585. Current status: RECRUITING.
What is the status of NCT05733585?
The current status of NCT05733585 (Clinical Study of Patients Treated With PuraBond Haemostatic Agent During Abdominal Aorta Open Repair) is: RECRUITING.
When did Clinical Study of Patients Treated With PuraBond Haemostatic Agent During Abdominal Aorta Open Repair start?
Clinical Study of Patients Treated With PuraBond Haemostatic Agent During Abdominal Aorta Open Repair started on 2023-02-15.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.